The global cellsurface marker detection market is expected to reach USD 6.49
billion by 2022, according to a new report by Grand View Research, Inc. This
growth in demand can be attributed to rise in incidence of oncology diseases
and other cell-associated disorders.
Rapid introduction of advancements and
automations in clinical laboratories is a key factor affecting this industry.
Incorporation of novel algorithms pertaining to diagnosis and prognosis of
chronic disorders is expected to fuel demand of this market in the coming
years.
Requirement of solutions for data handling
and interpretation of clinical conditions based on obtained results are anticipated
to enhance potential for R&D in this sector, consequently driving market
growth over the forecast period.
Browse full report by Grand View
Research : http://www.grandviewresearch.com/industry-analysis/cell-surface-marker-detection-market
Further key findings from the report suggest:
·
Flow cytometry devices accounted for over
70% of the revenue generated in the industry for 2014. This large share can be
attributed to the growing advancement in these instruments such as enhancement
in efficiency and resolution of fluorescence-based cytometric detectors.
Furthermore, presence of large product portfolio of different industry players
operating in cytometry is responsible for large market share of this
technique.
·
Disease diagnosis and identification
accounted for over 50% of the revenue generated in the market for 2014. High
incidence rate of cell-associated disorders and oncology diseases that need to
be treated in order to curb the mortality rate are the major drivers for growth
of this segment.
·
Determination of novel drug targets and
development of biopharmaceuticals for prognosis of chronic diseases is
anticipated to propel growth of research and drug discovery sub-segment in the
coming years. With expected development of this segment, the sector will
witness lucrative growth over the forecast period.
·
North America accounted for the largest
share of this sector for 2014, as there are is significantly high number of
research and development projects ongoing in the region related to cytological
investigation for proteomics, genomics, and drug and vaccine development.
Growing need for biopharmaceuticals is also anticipated to fuel regional
growth.
·
North America dominated the industry in
2014, with revenue estimated at USD 999.0 million. Presence of sophisticated
healthcare infrastructure and favorable government initiatives with respect to
analytical techniques and their applications for disease diagnosis and drug
development are some key factors likely to drive growth.
·
Asia Pacific is expected to witness
lucrative growth from 2015 to 2022 due to the presence of high-unmet medical
needs coupled with rapidly rising healthcare R&D investment and growing
medical expenditures in emerging economies of India and China
·
Key participants of the cell surface marker
detection industry include Siemens Healthcare, Nihon Kohden Corporation,
Sartorius, Janssen Diagnostics Inc., Grifols SA, Thermo Fisher Scientific,
BioRad Laboratories Inc., and F. Hoffman La Roche Ltd.
·
These participants are involved in R&D
for production of cell-specific antibodies and collaborations with smaller
entities operating in the market as well as with academic research laboratories
in order to maintain their market position and enter the untapped market
regions
Browse more reports of this category by Grand View
Research: https://www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented cell
surface marker detection market on the basis of product, application, and
region:
Cell Surface Marker Detection Product Outlook (Market
Revenue in USD Million, 2012 - 2022 )
·
Flow Cytometry
·
Hematology Analyzers
·
Reagents & Kits
Cell Surface Marker Detection Application Outlook (Market
Revenue in USD Million, 2012 - 2022 )
·
Disease Diagnosis & Identification
·
Research & Drug Discovery
·
Others
Cell Surface Marker Detection Regional Outlook (Market
Revenue in USD Million, 2012 - 2022 )
·
North America
·
Europe
·
Asia Pacific
·
RoW
View press
release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-cell-surface-marker-detection-market
About Grand
View Research
Grand View Research, Inc. is a U.S. based market research and consulting
company, registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.